Mr. Weinand currently serves as President of CRC and is a member of the Board of Management. Previously, he was President, Global Commercialization & Portfolio Management in Osaka. During his 30 year career, he has held various responsibilities in commercial, operations and strategy in various therapeutic areas including cardiovascular diseases, oncology, dermatology, immunology, and respiratory and inflammatory diseases . These positions included heading business operations in markets in the United Kingdom, Asia-Pacific, Europe, the Middle East, Africa, and Latin America for companies including Pfizer and Bristol-Myers Squibb. He earned an M.S. in pharmacology and toxicology from Southhampton University.